← Open Payments lookup

AMANINDER GREWAL: Open Payments

NPI 1467166355 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$399 in 17 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,772 · 2025 $399

Food & beverage: $399
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$109
Alkermes, Inc.3$49
Lundbeck LLC2$48
Janssen Pharmaceuticals, Inc2$48
Vanda Pharmaceuticals Inc.2$38
Otsuka America Pharmaceutical, Inc.1$24
Collegium Pharmaceutical, Inc.1$19
Teva Pharmaceuticals USA, Inc.1$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Neurocrine BioSciences, Inc.1$16

Products named: COBENFY, ARISTADA, REXULTI, HETLIOZ, INVEGA SUSTENNA, ABILIFY MAINTENA, SPRAVATO, Jornay PM.

Industry payments across NY — which companies pay providers there.